To assess the impact of primary tumor HIF1α expression on breast tumor cell dissemination to the bone, we generated an immune-competent spontaneous murine mammary carcinoma model with mammary-specific deletion of Hif1α using the Cre-lox system. The gene discussed is HIF1A; the disease is breast neoplasm.